Xanax XR — Class II drug recall D-0444-2026
Ongoing recall by Viatris, Inc., reported 2026-04-15, distributed nationwide. Failed Dissolution Specifications
| Recall number | D-0444-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Viatris, Inc., Canonsburg, PA, United States |
| Recall initiated | 2026-03-17 |
| Classified | 2026-04-08 |
| Reported by FDA | 2026-04-15 |
| Distributed | Nationwide (US) |
| Reason classes | specification failure |
| NDC | 58151-0503, 58151-0503-91, 58151-0504, 58151-0504-91, 58151-0505, 58151-0505-91, 58151-0506, 58151-0506-91 |
| Lot numbers | 8177156 |
| Expiration dates | 2027-02-28 |
Product
Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Distributed by: Viatris Specialty LLC, Morgantown, WV 06506, U.S.A, Made in Ireland, NDC 58151-506-91
Reason for recall
Failed Dissolution Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0444-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.